Corpus StriatumSubstantia NigraBasal GangliaDopamine3,4-Dihydroxyphenylacetic AcidBrainBasal Ganglia DiseasesReceptors, DopamineNeuronsBerberineParkinson DiseaseCorpus LuteumGlobus PallidusParkinsonian DisordersRats, Sprague-DawleyCorpus CallosumOxidopamineTyrosine 3-MonooxygenaseRats, Inbred StrainsGangliaNeostriatumDopaminergic NeuronsMesencephalonParkinson Disease, SecondaryPutamen1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineSubstantia GelatinosaMPTP PoisoningCaudate NucleusRetinal Ganglion CellsNeural PathwaysBasal Ganglia HemorrhageGanglia, SpinalAgenesis of Corpus CallosumSubthalamic NucleusReceptors, Dopamine D2Ganglia, Sympatheticalpha-SynucleinTegmentum MesencephaliGanglia, AutonomicMagnetic Resonance ImagingSubstantia InnominataLevodopaThalamusTrigeminal GanglionApomorphineNerve DegenerationBasal Ganglia Cerebrovascular DiseaseDopamine AgentsDopamine AgonistsGanglia, ParasympatheticDopamine AntagonistsBehavior, AnimalGanglia, SensoryVentral Tegmental AreaReceptors, Dopamine D1AutoradiographyDopamine Plasma Membrane Transport ProteinsLewy BodiesMotor ActivityAction PotentialsDisease Models, AnimalHypokinesiaCerebral CortexImmunohistochemistrygamma-Aminobutyric AcidBrain MappingNerve Tissue ProteinsAntiparkinson AgentsQuinpiroleEntopeduncular NucleusElectric StimulationMovement DisordersBrain ChemistryHaloperidolRats, WistarStereotyped BehaviorStellate GanglionSynaptic TransmissionMice, Inbred C57BLHomovanillic AcidRewardBenzazepinesCell CountDeep Brain StimulationStereotaxic TechniquesNeurotoxinsHydroxydopaminesAnalysis of Variance1-Methyl-4-phenylpyridinium2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineTime FactorsDyskinesiasAmphetamineNeuroprotective AgentsSpiral GanglionAdrenergic AgentsMethamphetamineNodose GanglionFunctional Laterality